Weiss Multi Strategy Advisers LLC Tricida, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$8.51 - $13.6 $170,200 - $272,000
20,000 Added 100.0%
40,000 $419,000
Q2 2022

Aug 15, 2022
BUY
$7.31 - $11.85 $146,200 - $237,000
20,000 New
20,000 $194,000
Q3 2020

Nov 16, 2020
SELL
$8.56 - $26.93 $86,019 - $270,619
-10,049 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$21.21 - $31.55 $213,139 - $317,045
10,049 New
10,049 $276,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email